Top Markets
Coin of the day
Ember Therapeutics, Inc. Ember Therapeutics, Inc.

Ember Therapeutics, Inc.

EMBT
株式のランク #42686
Ember Therapeutics, Inc. operates as a biopharmaceutical company currently in... Ember Therapeutics, Inc. operates as a biopharmaceutical company currently in its clinical development phase. Its core mission involves exploring the therapeutic applications of bone morphogenetic protein-7 (BMP-7) to engineer regenerative treatments. These innovative therapies are designed to alter the course of osteoarthritis, reverse insulin resistance, and inhibit or undo organ fibrosis in diseases such as chronic kidney disease and Alport's syndrome, alongside metabolic conditions like obesity and type 2 diabetes. Among its leading BMP-7-based drug candidates, MT-006 has successfully completed a Phase 2a clinical trial focused on osteoarthritis. Furthermore, MT-007, aimed at CKD and Alport syndrome; MT-008, specifically for Alport syndrome; and MT-009, targeting metabolic disease, have all concluded their preclinical trial phases. The company also maintains a substantial intellectual property portfolio, encompassing approximately 450 patents related to BMP-7, its associated protein families, various derivatives, novel delivery systems, specialized formulations, supporting clinical data, and materials produced under current good manufacturing practices. Ember Therapeutics, Inc. was established in 2010 and is headquartered in New York, New York.
株価
$0.0001
最終同期: 2026-02-06
時価総額
$398.00
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Ember Therapeutics, Inc. (EMBT)

カテゴリー

Ember Therapeutics, Inc.(EMBT)の株価履歴
終値の最高値: $0.00 (2026-02-01)

終値の最安値: $1.22 (2015-10-01)
Ember Therapeutics, Inc. の株価履歴(2015 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 0.00%
2025 0.00%
2024 0.00%
2023 0.00%
2022 -66.67%
2021 -99.96%
2020 560.19%
2019 2.24%
2018 -60.00%
2017 -59.65%
2016 -36.01%
2015 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$527.87 36.13%
US
$873.57 37.02%
NL
$736.38 8.73%
CH
$263.09 20.45%
BE
$1.07K -5.56%
KR